It was a notable convergence of top practitioners in the health industry as Dexa Medica Nigeria organised a symposium on corticosteroidsat Westown Hotel, Lagos, recently.
Amongst the key names that graced the event, which was also used to formally launch Dexa Medica Nigeria, were Dr. Cyril Chukwu, consultant chest physician from the department of medicine, Lagos University Teaching Hospital (LUTH), who was also chairman of the occasion; Dr. Ige Adegbola, consultant family physician, Federal Medical Centre, Idi-Aba, Abeokuta; Pharm. Steve Onya, managing director, Chi Pharmaceutical Ltd; and Mr Anndy Sembiring, head of marketing and sales, overseas business unit, Dexa Medica, Indonesia.
In his keynote address, Dr. Ige Adegbola, who spoke on the topic, “Update in Corticosteriod Management: The Role of Methylprednisolone as Anti-Inflamatory Agent”, said that corticosteroids, which are anti-inflammatory medications, can be used to treat different health conditions.
He explained further that the medications can be used to treat allergic reactions like asthma, dermatitis, allergic rhinitis and urticarial, adding that they are also indicated in the treatment of collagen-vascular disorders like lupus erythematosus, rheumatoid arthritis as well as eye diseases like allergic conjunctivitis, choroiditis and optic neuritis.
Other conditions corticosteroids are indicated for, according to Dr. Adegbola are: GI diseases, haematological disorders, neurological disorders, pulmonary diseases, renal disorders, skin diseases, thyroid diseases, organs transplants, inflammation of bones and joints and infections like septicaemia, because corticosteroids are occasionally helpful to suppress excessive inflammation.
Mr Dony Hendrawan, product manager, overseas business unit, Dexa Medica, Indonesia, spoke on some of the brands from the stable of Dexa Medica. He said that the company are bringing products like Remopain, an NSAID with high efficacy as an analgesic; Stimuno, an adjuvant therapy that helps the immune system as well Glimvaz, indicated for the treatment of diabetes mellitus, among others, to help improve the healthcare delivery Nigerians.
Hendrawan stated that Dexa Medica has done bioequivalence studies for all its products, adding that the company is offering high quality products that are comparable to the original brands in efficacy and safety and are affordable and available all over the country.
L-R: Dr. Ige Adegbola, consultant physician, Federal Medical Centre, Abeokuta; Pharm. Steve Onya, managing director, Chi Pharmaceutical Ltd; and Mr Anndy Sembiring, head of marketing and sales, overseas business unit, Dexa Medica, Indonesia, during a symposium on corticosteroids organised by Dexa Medica Nigeria and held at Westown Hotel, Lagos, recently.